Healthcare

According to a market report by Lucintel, the future of the enteral feeding formula market looks promising with opportunities in the oncology, gastrointestinal disease, neurological disorder, and diabetic applications. The global enteral feeding formula market is expected to reach an estimated $9.2 billion by 2028 with a CAGR of 7.0% from 2023 to 2028. The major drivers for this market are increasing aging population, growing cases of chronic diseases, such as diabetes, cancer, gastrointestinal diseases, and neurological disorders, and rising awareness of the enteral nutrition benefits.



In this market, adults and pediatric are the major type segments. Lucintel forecasts that pediatric are expected to witness the higher growth over the forecast period due increasing preterm birth rate along with rising chronic condition in the pediatric patients.



Within this market, gastrointestinal diseases are expected to witness the highest growth over the forecast period due to increasing cases of gastrointestinal diseases and disorders among population.



North America is expected to remain the largest region over the forecast period due to rising incidence of chronic diseases in the region and increasing inclination of population towards enteral nutrition.

Abbott, Nestlé S.A., Danone S.A. , Fresenius Kabi , B. Braun Melsungen AG, Otsuka Holding, Nutritional Medicinals, Kate Farms, Medtrition , Victus, and Global Health Products are the major suppliers in the global enteral feeding formula market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global enteral feeding formula market by product, stage, application, end use industry, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global Enteral Feeding Formula 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global enteral feeding formula market by product, stage, application, end use industry, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the enteral feeding formula market by product (standard formula, disease specific, diabetic formulas, renal formulas, hepatic formula, pulmonary formulas, other disease specific formulas, peptide based formulas, and others), stage (adults and pediatric), application (oncology, gastrointestinal diseases, neurological disorders, diabetes, and others), end use industry (hospitals, long term care facilities, nursing homes, assisted living facilities, and home care agencies & hospices), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?